Lucia
Méndez Sánchez
Investigadora desde 2022
Instituto de Investigación Biomédica de Salamanca
Salamanca, EspañaPublicacións en colaboración con investigadores/as de Instituto de Investigación Biomédica de Salamanca (7)
2023
-
Prph2 knock-in mice recapitulate human central areolar choroidal dystrophy retinal degeneration and exhibit aberrant synaptic remodeling and microglial activation
Cell Death and Disease, Vol. 14, Núm. 11
2022
-
CRISPR/Cas9‐Directed Gene Trap Constitutes a Selection System for Corrected BCR/ABL Leukemic Cells in CML
International Journal of Molecular Sciences, Vol. 23, Núm. 12
2021
-
CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia
CRISPR Journal, Vol. 4, Núm. 4, pp. 519-535
-
Future approaches for treating chronic myeloid leukemia: Crispr therapy
Biology, Vol. 10, Núm. 2, pp. 1-16
2020
-
Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology
Molecular Biology Reports, Vol. 47, Núm. 2, pp. 1381-1391
-
Expression and functional analysis of the hydrogen peroxide biosensors HyPer and HyPer2 in C2C12 myoblasts/myotubes and single skeletal muscle fibres
Scientific Reports, Vol. 10, Núm. 1
2019
-
Splice donor site sgRNAs enhance CRISPR/ Cas9-mediated knockout efficiency
PLoS ONE, Vol. 14, Núm. 5